Frontiers in Pharmacology | Pharmacology of Anti-Cancer Drugs

Original Research

Published on 13 Aug 2024

Transcription factor ZEB1 coordinating with NuRD complex to promote oncogenesis through glycolysis in colorectal cancer

in Pharmacology of Anti-Cancer Drugs

Tianyang Gao
Xinhui Hao
Jingyao Zhang
Miaomiao Huo
Ting Hu
Tianyu Ma
Hefen Yu
Xu Teng
Yong Wang
Yunkai Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1435269

2,052 views
2 citations

Systematic Review

Published on 13 Aug 2024

Knowledge mapping of metformin use on cancers: a bibliometric analysis (2013–2023)

in Pharmacology of Anti-Cancer Drugs

Chaomin Pan
Yiyi Wei
Jingping Dai
Li Yang
Zhuoyu Ding
Xinke Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1388253

2,550 views

Case Report

Published on 13 Aug 2024

Case report: Lichenoid eruption under immunotherapy with MK-4830 and pembrolizumab in a breast cancer patient

in Pharmacology of Anti-Cancer Drugs

Zofia Kachlik
Izabela Błażewicz
Aleksandra Ciarka
Roman J. Nowicki

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1445685

2,249 views
1 citation

Original Research

Published on 13 Aug 2024

Mn-ZIF nanozymes kill tumors by generating hydroxyl radical as well as reversing the tumor microenvironment

in Pharmacology of Anti-Cancer Drugs

Jiyu Han
Hairong Ma
Songtao Ai
Daqian Wan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1441818

1,204 views

Editorial

Published on 13 Aug 2024

Editorial: Hypoxia and angiogenesis in cancer

in Pharmacology of Anti-Cancer Drugs

Mohammad Malekan
Nicholas Denko
Lorenzo Mortara
Appu Rathinavelu
Mohammad Mahdi Parvizi
Umamaheswari Natarajan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1448204

1,204 views

Case Report

Published on 13 Aug 2024

Case report: Pyrotinib and tegafur combined with radiotherapy achieved notable response in HER2-amplified rectal cancer with multiple metastases after multiline treatments

in Pharmacology of Anti-Cancer Drugs

Peng Huang
Feng Wen
Xin Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1431542

1,165 views
1 citation

Original Research

Published on 12 Aug 2024

Systematic bioinformatics analysis reveals the role of shikonin in blocking colon cancer progression by identifying senescence-induced genes

in Pharmacology of Anti-Cancer Drugs

Wenna Liu
Yujia Zhao
Qingqing Liu
Dan Wu
Wenxuan Li
Zhenkai Fu
Le Yang
Ying Liang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1360587

1,928 views

Original Research

Published on 09 Aug 2024

Phosphoenolpyruvate carboxykinase 2-mediated metabolism promotes lung tumorigenesis by inhibiting mitochondrial-associated apoptotic cell death

in Pharmacology of Anti-Cancer Drugs

Jing Zhang
Wenjuan He
Dongmei Liu
Wenyu Zhang
Huan Qin
Song Zhang
Ailan Cheng
Qiang Li
Feilong Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1434988

2,577 views
4 citations

Original Research

Published on 09 Aug 2024

Integrating network pharmacology, molecular docking and experimental verification to reveal the mechanism of artesunate in inhibiting choroidal melanoma

in Pharmacology of Anti-Cancer Drugs

Qing-yue Ma
Yi-chong Liu
Qian Zhang
Wen-dan Yi
Ying Sun
Xiao-di Gao
Xin-tong Zhao
Hao-wen Wang
Ke Lei
Wen-juan Luo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1448381

4,230 views
4 citations

Original Research

Published on 09 Aug 2024

Prognostic analysis of patients with gastric cancer based on N6-methyladenosine modification patterns and tumor microenvironment characterization

in Pharmacology of Anti-Cancer Drugs

Miaomiao Huo
Min Zhang
Jingyao Zhang
Yong Wang
Ting Hu
Tianyu Ma
Yinuo Wang
Baowen Yuan
Hao Qin
Xu Teng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1445321

1,765 views

Original Research

Published on 09 Aug 2024

Xiaoyaosan formula augments adjuvant therapy and enhances postoperative breast cancer care

in Pharmacology of Anti-Cancer Drugs

Chao Wang
Lianfang Yin

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1388646

1,446 views

Review

Published on 08 Aug 2024

Therapeutic targeting of PARP with immunotherapy in acute myeloid leukemia

in Pharmacology of Anti-Cancer Drugs

Xing Bian
Wenli Liu
Kaijin Yang
Chuanbo Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1421816

2,494 views

Original Research

Published on 08 Aug 2024

The critical role of glutamine and fatty acids in the metabolic reprogramming of anoikis-resistant melanoma cells

in Pharmacology of Anti-Cancer Drugs

S. Peppicelli
T. Kersikla
G. Menegazzi
E. Andreucci
J. Ruzzolini
C. Nediani
F. Bianchini
L. Calorini

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1422281

2,168 views
5 citations

Original Research

Published on 08 Aug 2024

Multidimensional role of adapalene in regulating cell death in multiple myeloma

in Pharmacology of Anti-Cancer Drugs

Xinya Cao
Jie Xiang
Qi Zhang
Jinwen Liu
Dongming Zhou
Yong Xu
Peipei Xu
Bing Chen
Hua Bai

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1415224

2,262 views

Original Research

Published on 07 Aug 2024

Circ-CDK8 regulates SLC7A11-mediated ferroptosis by inhibiting miR-615-5p to promote progression in oral squamous cell carcinomas

in Pharmacology of Anti-Cancer Drugs

Kai Sun
Ling Gao
Shaoming Li
Jingjing Zheng
Zhuang Zhu
Keqian Zhi
Wenhao Ren

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1432520

1,965 views
3 citations

Brief Research Report

Published on 07 Aug 2024

The first-in-class pro-apoptotic peptide PEP-010 is effective in monotherapy and in combination with paclitaxel on resistant ovarian adenocarcinoma cell models

in Pharmacology of Anti-Cancer Drugs

Aline Lacroix
Rayan Farhat
Aude Robert
Catherine Brenner
Joëlle Wiels
Diego Germini

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1444973

2,408 views
1 citation